Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Oettl, K; Malle, E; Grillhofer, H; Sattler, W; Kostner, GM.
Cholesterol metabolism in cells with different peroxisomal defects.
Clin Chim Acta. 1996; 251(2):131-143 Doi: 10.1016%2F0009-8981%2896%2906301-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Führende Autor*innen der Med Uni Graz
Kostner Gerhard
Öttl Karl
Co-Autor*innen der Med Uni Graz
Malle Ernst
Sattler Wolfgang
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
We showed previously that cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin is increased in steps prior to mevalonate, whereas low-density-lipoprotein(LDL)-receptor activities were not different from control fibroblasts. Here, the suppression of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity by lovastatin was studied both in dermal fibroblasts from patients with different peroxisomal defects and in a Chinese hamster ovary (CHO) cell line lacking morphologically intact peroxisomes. In addition, the formation of intracellular cholesteryl esters (a measure of acyl-CoA:cholesterol acyltransferase(ACAT)-activity) stimulated by exogenous LDL was investigated. A dose-dependent suppression of cholesterol biosynthesis by lovastatin at concentrations of 1-50 mumol/l was observed which was comparable in normal and peroxisomal-disease fibroblasts. ACAT activity was measured in the absence and presence of exogenous LDL using [3H]oleate as a substrate for cholesterol ester synthesis. The basal esterification rate was equal or lower in peroxisomal-defective fibroblasts compared with controls. In the presence of exogenous LDL, cholesterol esterification was significantly impaired in all defective cells in comparison with normal fibroblasts. We conclude that changes in cholesterol homeostasis in peroxisomal diseased fibroblasts be related to cholesterol ester formation.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Anticholesteremic Agents - pharmacology
CHO Cells - pharmacology
Cholesterol - biosynthesis
Cricetinae - biosynthesis
Down-Regulation - drug effects
Enzyme Inhibitors - pharmacology
Fatty Acids - metabolism
Fibroblasts - drug effects
Homeostasis - drug effects
Humans - drug effects
Hydroxymethylglutaryl CoA Reductases - metabolism
Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism
Lipoproteins - biosynthesis
Lovastatin - pharmacology
Oleic Acid - metabolism
Peroxisomal Disorders - enzymology

Find related publications in this database (Keywords)
Acat
Lovastatin
Peroxisomes
Zellweger Syndrome
Low Density Lipoproteins
© Med Uni Graz Impressum